Skip to search.
 TSX Down 0.55% TSX Ventures Down 1.35%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.54 Down 0.20(7.30%) May 4, 4:00PM EDT
Prev Close:2.74
Open:2.68
Bid:2.14 x 100
Ask:3.50 x 3000
1y Target Est:5.00
Beta:1.32029
Earnings Date:Aug 2 - Aug 8 (Est.)
Day's Range:2.40 - 2.72
52wk Range:1.88 - 4.33
Volume:589,173
Avg Vol (3m):461,152
Market Cap:230.01M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RIGLDown 7.30%230.01M
AMGNDown 1.39%115.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.44
Quarterly EPS Est (Jun-16) :-0.19
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel and targeted drug candidates in the therapeutic areas of immunology, oncology, and immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback